CN102302877A - 生物防护过滤介质及其应用 - Google Patents
生物防护过滤介质及其应用 Download PDFInfo
- Publication number
- CN102302877A CN102302877A CN201110145600A CN201110145600A CN102302877A CN 102302877 A CN102302877 A CN 102302877A CN 201110145600 A CN201110145600 A CN 201110145600A CN 201110145600 A CN201110145600 A CN 201110145600A CN 102302877 A CN102302877 A CN 102302877A
- Authority
- CN
- China
- Prior art keywords
- filter medium
- adsorption layer
- lysine
- poly
- biological protection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000894006 Bacteria Species 0.000 claims abstract description 41
- 241000700605 Viruses Species 0.000 claims abstract description 38
- 238000001179 sorption measurement Methods 0.000 claims description 46
- 239000010410 layer Substances 0.000 claims description 43
- 238000000034 method Methods 0.000 claims description 38
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 claims description 30
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 claims description 29
- 229920001345 ε-poly-D-lysine Polymers 0.000 claims description 28
- 230000008569 process Effects 0.000 claims description 8
- 239000011241 protective layer Substances 0.000 claims description 6
- 102000009112 Mannose-Binding Lectin Human genes 0.000 claims description 5
- 108010087870 Mannose-Binding Lectin Proteins 0.000 claims description 5
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical group [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 3
- 239000000443 aerosol Substances 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims description 2
- 238000010521 absorption reaction Methods 0.000 abstract description 8
- 208000006673 asthma Diseases 0.000 abstract description 7
- 239000000835 fiber Substances 0.000 abstract description 7
- 230000000241 respiratory effect Effects 0.000 abstract description 6
- 239000013566 allergen Substances 0.000 abstract description 5
- 239000003446 ligand Substances 0.000 abstract description 4
- 230000009870 specific binding Effects 0.000 abstract description 4
- 208000035473 Communicable disease Diseases 0.000 abstract description 2
- 230000005540 biological transmission Effects 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 description 22
- 102000005962 receptors Human genes 0.000 description 22
- 239000000370 acceptor Substances 0.000 description 19
- 239000002158 endotoxin Substances 0.000 description 19
- WQVJHHACXVLGBL-GOVYWFKWSA-N polymyxin B1 Chemical compound N1C(=O)[C@H](CCN)NC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)CCCC[C@H](C)CC)CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1CC1=CC=CC=C1 WQVJHHACXVLGBL-GOVYWFKWSA-N 0.000 description 19
- 230000000694 effects Effects 0.000 description 14
- 238000001914 filtration Methods 0.000 description 14
- 239000000463 material Substances 0.000 description 12
- 229920006008 lipopolysaccharide Polymers 0.000 description 11
- 241000712461 unidentified influenza virus Species 0.000 description 11
- 101710186708 Agglutinin Proteins 0.000 description 10
- 101710146024 Horcolin Proteins 0.000 description 10
- 101710189395 Lectin Proteins 0.000 description 10
- 101710179758 Mannose-specific lectin Proteins 0.000 description 10
- 101710150763 Mannose-specific lectin 1 Proteins 0.000 description 10
- 101710150745 Mannose-specific lectin 2 Proteins 0.000 description 10
- 239000000910 agglutinin Substances 0.000 description 10
- 102000004169 proteins and genes Human genes 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 10
- KDXKERNSBIXSRK-RXMQYKEDSA-N D-lysine Chemical compound NCCCC[C@@H](N)C(O)=O KDXKERNSBIXSRK-RXMQYKEDSA-N 0.000 description 9
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 9
- 241000588724 Escherichia coli Species 0.000 description 9
- 238000013461 design Methods 0.000 description 9
- 238000001802 infusion Methods 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- 108090000765 processed proteins & peptides Proteins 0.000 description 7
- 230000003612 virological effect Effects 0.000 description 7
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 6
- 229940098773 bovine serum albumin Drugs 0.000 description 6
- 239000000428 dust Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 230000002265 prevention Effects 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 5
- 229920001184 polypeptide Polymers 0.000 description 5
- 102000004196 processed proteins & peptides Human genes 0.000 description 5
- 241000193468 Clostridium perfringens Species 0.000 description 4
- 229920002527 Glycogen Polymers 0.000 description 4
- 241000315672 SARS coronavirus Species 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 230000003385 bacteriostatic effect Effects 0.000 description 4
- 208000030303 breathing problems Diseases 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 229940096919 glycogen Drugs 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 208000023504 respiratory system disease Diseases 0.000 description 4
- 101710154606 Hemagglutinin Proteins 0.000 description 3
- 102000004856 Lectins Human genes 0.000 description 3
- 108090001090 Lectins Proteins 0.000 description 3
- 101710093908 Outer capsid protein VP4 Proteins 0.000 description 3
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 3
- 101710176177 Protein A56 Proteins 0.000 description 3
- 238000004378 air conditioning Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000000185 hemagglutinin Substances 0.000 description 3
- 230000002163 immunogen Effects 0.000 description 3
- 206010022000 influenza Diseases 0.000 description 3
- 239000002523 lectin Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 244000000010 microbial pathogen Species 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000004745 nonwoven fabric Substances 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 206010049244 Ankyloglossia congenital Diseases 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241000711573 Coronaviridae Species 0.000 description 2
- 102100026553 Mannose-binding protein C Human genes 0.000 description 2
- 201000003176 Severe Acute Respiratory Syndrome Diseases 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- 102000002689 Toll-like receptor Human genes 0.000 description 2
- 108020000411 Toll-like receptor Proteins 0.000 description 2
- 206010064097 avian influenza Diseases 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000000280 densification Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 231100000284 endotoxic Toxicity 0.000 description 2
- 230000002346 endotoxic effect Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 238000003375 selectivity assay Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 1
- WFJIVOKAWHGMBH-UHFFFAOYSA-N 4-hexylbenzene-1,3-diol Chemical compound CCCCCCC1=CC=C(O)C=C1O WFJIVOKAWHGMBH-UHFFFAOYSA-N 0.000 description 1
- 208000035404 Autolysis Diseases 0.000 description 1
- 108010041397 CD4 Antigens Proteins 0.000 description 1
- 206010057248 Cell death Diseases 0.000 description 1
- 101150048348 GP41 gene Proteins 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 101000831567 Homo sapiens Toll-like receptor 2 Proteins 0.000 description 1
- 101000669447 Homo sapiens Toll-like receptor 4 Proteins 0.000 description 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 229920000715 Mucilage Polymers 0.000 description 1
- SQVRNKJHWKZAKO-PFQGKNLYSA-N N-acetyl-beta-neuraminic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-PFQGKNLYSA-N 0.000 description 1
- 208000002606 Paramyxoviridae Infections Diseases 0.000 description 1
- 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 description 1
- 102100024333 Toll-like receptor 2 Human genes 0.000 description 1
- 102100039360 Toll-like receptor 4 Human genes 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000001408 fungistatic effect Effects 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 210000003712 lysosome Anatomy 0.000 description 1
- 230000001868 lysosomic effect Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- XDRYMKDFEDOLFX-UHFFFAOYSA-N pentamidine Chemical compound C1=CC(C(=N)N)=CC=C1OCCCCCOC1=CC=C(C(N)=N)C=C1 XDRYMKDFEDOLFX-UHFFFAOYSA-N 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920000729 poly(L-lysine) polymer Polymers 0.000 description 1
- 239000003910 polypeptide antibiotic agent Substances 0.000 description 1
- 150000004804 polysaccharides Polymers 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 210000003079 salivary gland Anatomy 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000028043 self proteolysis Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 125000005629 sialic acid group Chemical group 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 210000002845 virion Anatomy 0.000 description 1
Images
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Filtering Materials (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110145600 CN102302877B (zh) | 2011-06-01 | 2011-06-01 | 生物防护过滤介质及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110145600 CN102302877B (zh) | 2011-06-01 | 2011-06-01 | 生物防护过滤介质及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102302877A true CN102302877A (zh) | 2012-01-04 |
CN102302877B CN102302877B (zh) | 2013-06-12 |
Family
ID=45376848
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110145600 Ceased CN102302877B (zh) | 2011-06-01 | 2011-06-01 | 生物防护过滤介质及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102302877B (zh) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104583395A (zh) * | 2012-07-06 | 2015-04-29 | 昆塔麦特利斯株式会社 | 用于捕获和释放微生物的微结构体 |
CN105771421A (zh) * | 2016-03-09 | 2016-07-20 | 仙桃永利医疗用品有限公司 | 一种过滤口罩用无纺布复合材料 |
CN107373823A (zh) * | 2017-09-22 | 2017-11-24 | 山东工大新材料研究院有限公司 | 一种新型防雾霾口罩 |
CN107467748A (zh) * | 2017-09-22 | 2017-12-15 | 山东工大新材料研究院有限公司 | 新型防雾霾口罩制作方法 |
CN109700100A (zh) * | 2017-10-25 | 2019-05-03 | 深圳瑞祥居科技发展有限公司 | 一种面部防护用品 |
CN109806667A (zh) * | 2019-01-16 | 2019-05-28 | 苏本龙 | 蛋白质病毒防护阻隔生物制剂及制备方法 |
CN111802407A (zh) * | 2020-06-04 | 2020-10-23 | 中国人民解放军总医院 | 一种组合物及其制备和应用 |
CN112255221A (zh) * | 2020-10-16 | 2021-01-22 | 航科中投生物技术(北京)有限公司 | 一种生物防护过滤介质浓度及喷涂效果的比色鉴定方法 |
CN113731020A (zh) * | 2021-09-06 | 2021-12-03 | 赵勤 | 一种新型生物凝胶医用口罩滤材及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1093823A1 (fr) * | 1999-10-20 | 2001-04-25 | Maco Pharma | Unité de filtration d'une substance virucide |
US20040144255A1 (en) * | 2001-04-24 | 2004-07-29 | Ulrich Lersch | Respiratory air filter |
CN2638771Y (zh) * | 2003-07-17 | 2004-09-08 | 杨红恩 | 纳米抗菌口罩 |
CN102061614A (zh) * | 2009-11-12 | 2011-05-18 | 西安交大保赛生物技术股份有限公司 | 双模式吸附高效抗菌、抗病毒材料 |
-
2011
- 2011-06-01 CN CN 201110145600 patent/CN102302877B/zh not_active Ceased
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1093823A1 (fr) * | 1999-10-20 | 2001-04-25 | Maco Pharma | Unité de filtration d'une substance virucide |
US20040144255A1 (en) * | 2001-04-24 | 2004-07-29 | Ulrich Lersch | Respiratory air filter |
CN2638771Y (zh) * | 2003-07-17 | 2004-09-08 | 杨红恩 | 纳米抗菌口罩 |
CN102061614A (zh) * | 2009-11-12 | 2011-05-18 | 西安交大保赛生物技术股份有限公司 | 双模式吸附高效抗菌、抗病毒材料 |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104583395A (zh) * | 2012-07-06 | 2015-04-29 | 昆塔麦特利斯株式会社 | 用于捕获和释放微生物的微结构体 |
CN104583395B (zh) * | 2012-07-06 | 2019-01-29 | 昆塔麦特利斯株式会社 | 用于捕获和释放微生物的微结构体 |
US10253348B2 (en) | 2012-07-06 | 2019-04-09 | Quantamatrix Inc. | Microstructure for capturing and releasing microorganism |
CN105771421A (zh) * | 2016-03-09 | 2016-07-20 | 仙桃永利医疗用品有限公司 | 一种过滤口罩用无纺布复合材料 |
CN107373823A (zh) * | 2017-09-22 | 2017-11-24 | 山东工大新材料研究院有限公司 | 一种新型防雾霾口罩 |
CN107467748A (zh) * | 2017-09-22 | 2017-12-15 | 山东工大新材料研究院有限公司 | 新型防雾霾口罩制作方法 |
CN109700100A (zh) * | 2017-10-25 | 2019-05-03 | 深圳瑞祥居科技发展有限公司 | 一种面部防护用品 |
CN109806667A (zh) * | 2019-01-16 | 2019-05-28 | 苏本龙 | 蛋白质病毒防护阻隔生物制剂及制备方法 |
CN109806667B (zh) * | 2019-01-16 | 2020-12-08 | 苏本龙 | 蛋白质病毒防护阻隔生物制剂及制备方法 |
CN111802407A (zh) * | 2020-06-04 | 2020-10-23 | 中国人民解放军总医院 | 一种组合物及其制备和应用 |
CN111802407B (zh) * | 2020-06-04 | 2021-11-23 | 中国人民解放军总医院 | 一种组合物及其制备和应用 |
CN112255221A (zh) * | 2020-10-16 | 2021-01-22 | 航科中投生物技术(北京)有限公司 | 一种生物防护过滤介质浓度及喷涂效果的比色鉴定方法 |
CN113731020A (zh) * | 2021-09-06 | 2021-12-03 | 赵勤 | 一种新型生物凝胶医用口罩滤材及其制备方法 |
CN113731020B (zh) * | 2021-09-06 | 2022-08-26 | 赵勤 | 一种新型生物凝胶医用口罩滤材及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102302877B (zh) | 2013-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102302877B (zh) | 生物防护过滤介质及其应用 | |
CN2692560Y (zh) | 空调和空气净化机 | |
KR102251918B1 (ko) | 에어로졸의 병원체를 불활성화시키는 물질, 장치 및 방법, 및 이의 제조방법 | |
Tiliket et al. | A new material for airborne virus filtration | |
CN2865826Y (zh) | 空气净化过滤器 | |
CN100387325C (zh) | 空气净化器 | |
US20100330141A1 (en) | Product for absorption purposes | |
BR0302962A (pt) | Meio filtrante microporoso, sistemas de filtração contendo o mesmo, e métodos de sua fabricação e uso | |
CN109924571B (zh) | 一种抗菌口罩 | |
Peng et al. | Integrated endotoxin-adsorption and antibacterial properties of platelet-membrane-coated copper silicate hollow microspheres for wound healing | |
CN105266238A (zh) | 一种基于氧化石墨烯的绿色防霾口罩及其制备方法 | |
CN102061614B (zh) | 双模式吸附高效抗菌、抗病毒材料 | |
CN105879665A (zh) | 一种用于空气净化器中的复合滤网 | |
CN102786709A (zh) | 一种具有抗菌功能的防水透气材料及其制备方法 | |
USRE49959E1 (en) | Anti-pathogen device | |
Lin et al. | One-pot fabrication and antimicrobial properties of novel PET nonwoven fabrics | |
US20060293263A1 (en) | Preparation for preventing contact of pathogenic matter with living organism | |
CN104904750A (zh) | 一种生物抗菌剂、其制备方法及其应用 | |
CN201630271U (zh) | 一种壳聚糖抗菌功能口罩 | |
CN208859813U (zh) | 一种负离子风口 | |
CN111165939A (zh) | 一种负离子抗菌防霾口罩 | |
US20230105070A1 (en) | Protective mask, air filtration element and air treatment element | |
KR20230066356A (ko) | 바이러스 감염 예방 복합제제 및 이의 제조/사용 방법과 용도 | |
CN111672204A (zh) | 一种含银滤芯及其制备方法以及一种口罩 | |
Fahma et al. | Production of cellulose and chitin/chitosan nanofibers-based masks for protecting against coronavirus: A new approach |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: BEIJING LANGKUN BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: LI HONG Effective date: 20140813 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100071 FENGTAI, BEIJING TO: 100070 FENGTAI, BEIJING |
|
TR01 | Transfer of patent right |
Effective date of registration: 20140813 Address after: 100070 202A building, 1 building, No. 8, Feng Feng Road, Fengtai District Science Town, Beijing, China Patentee after: Beijing langkun Biological Technology Co. Ltd. Address before: 100071 room 212, research building, Fengtai science and Technology Park, 8, Feng Qi Road, Beijing, Fengtai District Patentee before: Li Hong |
|
ASS | Succession or assignment of patent right |
Owner name: BEIJING HUILANG BIOLOCAL TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: BEIJING LANGKUN BIOTECHNOLOGY CO., LTD. Effective date: 20150601 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150601 Address after: 100070 Fengtai District Science City, Feng Feng Road, No. 8, building 320, room 1, No. Patentee after: Beijing Hui Long Biotechnology Co., Ltd. Address before: 100070 202A building, 1 building, No. 8, Feng Feng Road, Fengtai District Science Town, Beijing, China Patentee before: Beijing langkun Biological Technology Co. Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20161221 Address after: 100089 Beijing City, north of the West Sag in the hospital, No. 51, No. 4032 in the west of Haidian District Patentee after: Cai Limin Address before: 100070 Fengtai District Science City, Feng Feng Road, No. 8, building 320, room 1, No. Patentee before: Beijing Hui Long Biotechnology Co., Ltd. |
|
C56 | Change in the name or address of the patentee | ||
CP02 | Change in the address of a patent holder |
Address after: Yixian County Taiyuan street 074299 Hebei city of Baoding province No. 149 Patentee after: Cai Limin Address before: 100089 Beijing City, north of the West Sag in the hospital, No. 51, No. 4032 in the west of Haidian District Patentee before: Cai Limin |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130612 Termination date: 20180601 |
|
IW01 | Full invalidation of patent right | ||
IW01 | Full invalidation of patent right |
Decision date of declaring invalidation: 20181010 Decision number of declaring invalidation: 37403 Granted publication date: 20130612 |